Nebraska Hematology Oncology — Lincoln, Nebraska

Nebraska Hematology Oncology is a clinical research site located in Lincoln, Nebraska, United States 68506.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Hematology Oncology has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Solid Tumor, Adult, Pancreatic Cancer, Small Bowel Cancer.

Sponsors: Corbus Pharmaceuticals Inc., xCures, BeOne Medicines.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Hematology Oncology?

Nebraska Hematology Oncology has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Hematology Oncology conducted?

Nebraska Hematology Oncology has 5 clinical trials on record, with 3 currently active. Their work covers Solid Tumor, Adult, Pancreatic Cancer, Small Bowel Cancer.

Is Nebraska Hematology Oncology accredited by Crixeo Health?

Nebraska Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.